Free Trial

Pulmonx (LUNG) Competitors

Pulmonx logo
$1.61 -0.23 (-12.50%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.67 +0.06 (+3.66%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LUNG vs. BFLY, DCTH, TMCI, SNWV, CATX, CLPT, OM, RXST, NPCE, and NNOX

Should you be buying Pulmonx stock or one of its competitors? The main competitors of Pulmonx include Butterfly Network (BFLY), Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Sanuwave Health (SNWV), Perspective Therapeutics (CATX), ClearPoint Neuro (CLPT), Outset Medical (OM), RxSight (RXST), NeuroPace (NPCE), and Nano-X Imaging (NNOX). These companies are all part of the "medical equipment" industry.

Pulmonx vs. Its Competitors

Butterfly Network (NYSE:BFLY) and Pulmonx (NASDAQ:LUNG) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

Butterfly Network has a beta of 2.45, meaning that its stock price is 145% more volatile than the S&P 500. Comparatively, Pulmonx has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500.

Pulmonx has a net margin of -62.88% compared to Butterfly Network's net margin of -75.56%. Butterfly Network's return on equity of -29.97% beat Pulmonx's return on equity.

Company Net Margins Return on Equity Return on Assets
Butterfly Network-75.56% -29.97% -21.13%
Pulmonx -62.88%-66.36%-35.51%

Pulmonx has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Butterfly Network$82.06M4.25-$72.49M-$0.29-4.86
Pulmonx$83.79M0.77-$56.39M-$1.43-1.13

Butterfly Network currently has a consensus price target of $3.50, suggesting a potential upside of 148.23%. Pulmonx has a consensus price target of $7.66, suggesting a potential upside of 376.04%. Given Pulmonx's higher probable upside, analysts clearly believe Pulmonx is more favorable than Butterfly Network.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Butterfly Network
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Pulmonx
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.56

37.9% of Butterfly Network shares are owned by institutional investors. Comparatively, 91.0% of Pulmonx shares are owned by institutional investors. 25.2% of Butterfly Network shares are owned by company insiders. Comparatively, 6.8% of Pulmonx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Pulmonx had 10 more articles in the media than Butterfly Network. MarketBeat recorded 20 mentions for Pulmonx and 10 mentions for Butterfly Network. Butterfly Network's average media sentiment score of 0.82 beat Pulmonx's score of 0.01 indicating that Butterfly Network is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Butterfly Network
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Pulmonx
2 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Butterfly Network and Pulmonx tied by winning 8 of the 16 factors compared between the two stocks.

Get Pulmonx News Delivered to You Automatically

Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LUNG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LUNG vs. The Competition

MetricPulmonxMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$74.07M$2.04B$5.48B$9.51B
Dividend YieldN/AN/A4.73%4.09%
P/E Ratio-1.1333.7928.6723.80
Price / Sales0.7728.84373.9066.58
Price / CashN/A56.2135.4557.96
Price / Book0.748.978.275.55
Net Income-$56.39M-$62.31M$3.24B$259.03M
7 Day Performance-51.80%-8.15%-3.69%-4.59%
1 Month Performance-40.81%1.83%4.33%4.46%
1 Year Performance-74.80%21.01%25.95%18.03%

Pulmonx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LUNG
Pulmonx
3.855 of 5 stars
$1.61
-12.5%
$7.66
+376.0%
-75.2%$74.07M$83.79M-1.13250Trending News
Earnings Report
Analyst Forecast
High Trading Volume
BFLY
Butterfly Network
2.6405 of 5 stars
$1.89
+0.8%
$3.50
+85.7%
+36.9%$462.43M$82.06M-6.50460News Coverage
Analyst Downgrade
Gap Down
DCTH
Delcath Systems
2.5218 of 5 stars
$11.32
+0.6%
$24.00
+112.0%
+29.3%$391.80M$37.21M-22.6460Upcoming Earnings
Analyst Upgrade
TMCI
Treace Medical Concepts
2.4159 of 5 stars
$5.72
+1.2%
$10.52
+83.9%
-19.0%$355.33M$209.36M0.00250News Coverage
Positive News
Upcoming Earnings
SNWV
Sanuwave Health
2.2594 of 5 stars
$38.31
-2.4%
N/AN/A$336.26M$32.63M0.0040News Coverage
Analyst Forecast
Analyst Revision
CATX
Perspective Therapeutics
2.3837 of 5 stars
$4.31
+2.6%
$12.56
+191.3%
-72.5%$319.92MN/A0.0070
CLPT
ClearPoint Neuro
2.73 of 5 stars
$10.98
-0.5%
$25.00
+127.7%
+47.1%$308.72M$31.39M-14.45110Positive News
Analyst Forecast
Gap Down
OM
Outset Medical
1.7102 of 5 stars
$17.51
+0.5%
$29.50
+68.5%
-71.4%$308.72M$113.69M-0.60520Upcoming Earnings
RXST
RxSight
3.3717 of 5 stars
$7.35
flat
$17.50
+138.1%
-82.4%$298.68M$139.93M0.00220Trending News
Upcoming Earnings
NPCE
NeuroPace
3.264 of 5 stars
$9.36
+3.3%
$17.00
+81.6%
+24.5%$297.15M$79.91M0.00170News Coverage
NNOX
Nano-X Imaging
2.213 of 5 stars
$5.17
+0.6%
$9.50
+83.8%
-41.1%$296.98M$11.28M-5.74190News Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:LUNG) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners